Is there a role for probiotics in irritable bowel syndrome?

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

This brief review appraises the current evidence of the efficacy of probiotics, including lactobacilli, bifidobacteria, and VSL#3, in the treatment of irritable bowel syndrome (IBS). The mechanisms potentially important will be evaluated, with specific reference to immune function, effects on motility and intraluminal milieu. These experimental and clinical observations suggest that probiotics may play a role in the management of IBS.

Original languageEnglish (US)
JournalDigestive and Liver Disease
Volume38
Issue numberSUPPL. 2
DOIs
StatePublished - Dec 2006

Fingerprint

Irritable Bowel Syndrome
Probiotics
Bifidobacterium
Lactobacillus

Keywords

  • Bifidobacteria
  • Irritable bowel syndrome
  • Lactobacilli
  • Probiotics
  • VSL#3

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Is there a role for probiotics in irritable bowel syndrome? / Camilleri, Michael.

In: Digestive and Liver Disease, Vol. 38, No. SUPPL. 2, 12.2006.

Research output: Contribution to journalArticle

@article{3dbbee9919f3441e9b04b8e881c083b4,
title = "Is there a role for probiotics in irritable bowel syndrome?",
abstract = "This brief review appraises the current evidence of the efficacy of probiotics, including lactobacilli, bifidobacteria, and VSL#3, in the treatment of irritable bowel syndrome (IBS). The mechanisms potentially important will be evaluated, with specific reference to immune function, effects on motility and intraluminal milieu. These experimental and clinical observations suggest that probiotics may play a role in the management of IBS.",
keywords = "Bifidobacteria, Irritable bowel syndrome, Lactobacilli, Probiotics, VSL#3",
author = "Michael Camilleri",
year = "2006",
month = "12",
doi = "10.1016/S1590-8658(07)60007-3",
language = "English (US)",
volume = "38",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Is there a role for probiotics in irritable bowel syndrome?

AU - Camilleri, Michael

PY - 2006/12

Y1 - 2006/12

N2 - This brief review appraises the current evidence of the efficacy of probiotics, including lactobacilli, bifidobacteria, and VSL#3, in the treatment of irritable bowel syndrome (IBS). The mechanisms potentially important will be evaluated, with specific reference to immune function, effects on motility and intraluminal milieu. These experimental and clinical observations suggest that probiotics may play a role in the management of IBS.

AB - This brief review appraises the current evidence of the efficacy of probiotics, including lactobacilli, bifidobacteria, and VSL#3, in the treatment of irritable bowel syndrome (IBS). The mechanisms potentially important will be evaluated, with specific reference to immune function, effects on motility and intraluminal milieu. These experimental and clinical observations suggest that probiotics may play a role in the management of IBS.

KW - Bifidobacteria

KW - Irritable bowel syndrome

KW - Lactobacilli

KW - Probiotics

KW - VSL#3

UR - http://www.scopus.com/inward/record.url?scp=33846452536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846452536&partnerID=8YFLogxK

U2 - 10.1016/S1590-8658(07)60007-3

DO - 10.1016/S1590-8658(07)60007-3

M3 - Article

C2 - 17259088

AN - SCOPUS:33846452536

VL - 38

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - SUPPL. 2

ER -